Annovis Bio, Inc.ANVSNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.46
↑ 90% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthElevated
Average
-24.15
Historical baseline
PeriodValueYoY Change
2025-2.46+1.1%
2024-2.49+17.0%
2023-3.00+30.6%
2022-4.33+53.2%
2021-9.25-6.3%
2020-8.71+86.9%
2019-66.24-12.1%
2018-59.10+4.4%
2017-61.80-